The pharmaceutical industry has encountered previously unheard-of difficulties in recent years. The average cost of pharmaceuticals in the US has increased by 24% in the last three years due to safety concerns, problems with specific prescriptions, and competition from both non-generic and generic drugs. For individuals with private insurance, this led to a 4% decrease in prescription costs between 2010 and 2013.Emerging economies such as China, India, and Brazil have comparable challenges. One potential solution is to develop a range of vaccinations with therapeutic advantages.Antibiotics are necessary to treat bacterial infections and preserve population and individual health over the long run. However, antibiotic-resistant bacterial infections are a hazard to global health.